Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group

Background: There is ample evidence of important symptomatic efficacy of tumour necrosis factor α (TNFα) inhibition in ankylosing spondylitis (AS). Moreover, studies suggest that anti-TNF could be considered as the first disease controlling antirheumatic treatment (DC-ART) for AS. Objective: To dete...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pham, T, van der Heijde, D, Calin, A, Khan, M, van der Linden, S., Bellamy, N, Dougados, M
Format: Artigo
Jezik:Inglês
Izdano: 2003
Teme:
Extended Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754653/
https://ncbi.nlm.nih.gov/pubmed/12922951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.9.812
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items